Governance and Nominating Committee
Risk Oversight Committee
Science and Technology Committee
Harry A. Korman joined the Viatris board of directors after two years of service on the Mylan board, where he most recently chaired the Risk Oversight Committee and was a member of the Compliance, Governance & Nominating, and Science and Technology Committees. Korman previously served as Mylan’s global chief operating officer, president of Mylan North America and president of Mylan Pharmaceuticals Inc. He joined Mylan in 1996 after the company’s acquisition of UDL Laboratories, Inc., now known as Mylan Institutional Inc., where he served as its president. Korman also previously served as a director and vice chairman of the Generic Pharmaceutical Association, now known as the Association for Accessible Medicines, and was a director and vice chairman of the HDMA Foundation, which provides research and education focused on healthcare supply issues.